The oral microbiota in colorectal cancer is distinctive and predictive/Experiment 1

From BugSigDB


Reviewed Marked as Reviewed by Folakunmi on 2024-1-23

Curated date: 2022/07/05

Curator: Jeshudy

Revision editor(s): Jeshudy, WikiWorks, Atrayees, Folakunmi

Subjects

Location of subjects
Ireland
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Oral cavity Bucca,Buccal cavity,Cavity of mouth,Oral cavity,oral cavity
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Colorectal cancer cancer of colorectum,cancer of large bowel,cancer of large intestine,cancer of the large bowel,colon cancer,colorectal cancer,colorectum cancer,CRC,large intestine cancer,malignant colorectal neoplasm,malignant colorectal tumor,malignant colorectum neoplasm,malignant large bowel neoplasm,malignant large bowel tumor,malignant large intestine neoplasm,malignant large intestine tumor,malignant neoplasm of colorectum,malignant neoplasm of large bowel,malignant neoplasm of large intestine,malignant neoplasm of the large bowel,malignant neoplasm of the large intestine,malignant tumor of large bowel,malignant tumor of large intestine,malignant tumor of the large bowel,malignant tumor of the large intestine,Colorectal cancer
Group 0 name Corresponds to the control (unexposed) group for case-control studies
Healthy Controls
Group 1 name Corresponds to the case (exposed) group for case-control studies
Individuals with CRC
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Individuals diagnosed with CRC
Group 0 sample size Number of subjects in the control (unexposed) group
103
Group 1 sample size Number of subjects in the case (exposed) group
99
Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
1 month

Lab analysis

Sequencing type
16S
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
V3-V4
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
raw counts
Statistical test
ANCOM
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
Yes


Signature 1

Reviewed Marked as Reviewed by Folakunmi on 2024-1-23

Curated date: 2022/07/05

Curator: Jeshudy

Revision editor(s): Jeshudy, Atrayees

Source: Figure 5(B)

Description: Scatterplot of the colonic prevalence of bacterial OTUs associated with oral pathogen and biofilm CAGs.

Abundance in Group 1: increased abundance in Individuals with CRC

NCBI Quality ControlLinks
Dialister
Fusobacterium
Gemella
Parvimonas
Peptostreptococcus
Solobacterium
Streptococcus

Revision editor(s): Jeshudy, Atrayees

Signature 2

Reviewed Marked as Reviewed by Folakunmi on 2024-1-23

Curated date: 2022/07/05

Curator: Jeshudy

Revision editor(s): Jeshudy, Atrayees, Folakunmi

Source: Figure 5(B)

Description: Scatterplot of the colonic prevalence of bacterial OTUs associated with oral pathogen and biofilm CAGs.

Abundance in Group 1: decreased abundance in Individuals with CRC

NCBI Quality ControlLinks
Actinomyces
Haemophilus
Veillonella

Revision editor(s): Jeshudy, Atrayees, Folakunmi